After completion of phase Ia, a phase Ib dose expansion was conducted to determine preliminary efficacy in GVHD prevention. For the phase Ib expansion, a historical benchmark for day 100 grade II-IV ...

Replacing transplant and chemo with CI-based therapy and ISRT maintains survival, reduces side effects in younger patients ...

TScan Therapeutics is developing TSC-101 and multiplex TCR-Ts for cancer treatment. See why TCRX stock holds potential with ...

Anthony Stein, MD, assessed total marrow and lymphoid irradiation with post-transplant cyclophosphamide in patients with ...

Presented updated data from ongoing ALLOHA™ Phase 1 heme trial at the 66th ASH Annual Meeting and ExpositionIND application cleared for seventh ...

The researchers found that ferulic acid significantly reduced cell viability in all three cell lines in a dose-dependent manner, with the HCT-116 cells showing the greatest sensitivity.

Cosette has a long history in quality manufacturing of complex dosage forms including topical ... WELCHOL®, AZOR®, TRIBENZOR®, BENICAR®, BENICAR® HCT, EFFIENT®, EVOXAC®, ANUCORT-HC ...

While high-dose chemotherapy and autologous hematopoietic cell transplantation (HCT) can deepen remissions and improve outcomes for multiple myeloma, these treatments come with significant risks ...